倍他米松17,21-二丙酸酯

Name: 倍他米松17,21-二丙酸酯
Brand: 济南圣和化工有限公司

CAS 5593-20-4C28H37FO7MW 504.6

本页收录倍他米松17,21-二丙酸酯，CAS 登记号为 5593-20-4，分子式 C28H37FO7，分子量 504.6，归类于医药中间体及原料药。作为主营产品之一，济南圣和化工有限公司可提供从公斤级到吨级的稳定供货，随货附 COA 与质检资料。

产品概览

CAS号	5593-20-4
分子式	C28H37FO7
分子量	504.6
LogP	4.07
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	医药中间体及原料药
类别	医药中间体及原料药

应用领域

医药中间体及原料药

倍他米松17,21-二丙酸酯主要应用于医药中间体及原料药。具体使用工况下的添加量与规格要求，欢迎与技术团队沟通确认。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

采购提示：本产品按按订单/批次确认(不公开发布)起订发货，收到货物后请先核对包装完好性再行入库。储存条件为阴凉干燥、密封保存；如需 MSDS 或运输说明，可在询价时一并索取。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

选择济南圣和化工有限公司的理由：产品信息透明（含 CAS、分子式、理化参数）、报价响应快（一个工作日内）、单证齐全（COA/MSS/质检资料按需提供）、支持批量与长期协议供货。如需倍他米松17,21-二丙酸酯以外的配套原料，也欢迎一并列出需求清单。

常见问题

倍他米松17,21-二丙酸酯的 CAS 号是多少？

倍他米松17,21-二丙酸酯的 CAS 号为 5593-20-4。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

倍他米松17,21-二丙酸酯有什么用途？

主要应用于医药中间体及原料药。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Betamethasone Dipropionate · CAS 5593-20-4 · C28H37FO7. UNII 826Y60901U. LogP: 4.07.

Identification

CAS Registry Number	5593-20-4
PubChem CID	21800
Molecular formula	C28H37FO7
IUPAC name	[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
UNII (FDA)	826Y60901U

Computed Descriptors

Molecular Weight	504.6
XLogP3	3.6
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	8
Exact Mass	504.25233168
Monoisotopic Mass	504.25233168
Topological Polar Surface Area	107
Heavy Atom Count	36
Formal Charge	0

Physical & Chemical Properties

LogP	4.07

Physical description & handling notes

218.1 Å² [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Regulatory Status

GHS notification summary	1.6% (2 / 127)

GHS Hazard Classification

GHS notification summary	1.6% (2 / 127)
Reported hazard statements	H330 (40.9%), H360 (37.8%), H361 (45.7%), H372 (50.4%), H410 (50.4%)

This chemical does not meet GHS hazard criteria for 1.6% (2 of 127) of reports.

H330 (40.9%): Fatal if inhaled [Danger Acute toxicity, inhalation]

Documented Uses

Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Substances that reduce or suppress INFLAMMATION.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]
BETAMETHASONE DIPROPIONATE USP, 0.05%
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Synonyms

BETAMETHASONE DIPROPIONATE; 5593-20-4; Diprosone; Diprolene; Alphatrex; Maxivate; Betamethasone 17,21-dipropionate; Rinderon DP; Diprolene AF; Diprospan; Sch 11460; Sernivo; Sch-11460; DTXSID2022672; beta-Methasone 17,21-dipropionate; Betamethasone (as dipropionate)

Frequently Asked Questions

What are the CAS number and molecular formula of Betamethasone Dipropionate?

CAS 5593-20-4; molecular formula C28H37FO7; molecular weight — g/mol.

What other names is Betamethasone Dipropionate known by?

BETAMETHASONE DIPROPIONATE, 5593-20-4, Diprosone, Diprolene, Alphatrex, Maxivate.

Is Betamethasone Dipropionate classified as hazardous?

1.6% of GHS notifications report no hazard classification (2 of 127).

What are the key physical properties of Betamethasone Dipropionate?

LogP: 4.07.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.